Clinical Trials in Houston

Showing 12121-12140 of 17,885 trials

Trial of Dasatinib in Advanced Sarcomas

NCT00464620

This study will examine the response rate and the 6-month progression-free survival rates of subjects with advanced sarcoma treated with dasatinib.

RhabdomyosarcomaMalignant Peripheral Nerve Sheath TumorsChondrosarcoma+7 more

Sarcoma Alliance for Research through Collaboration366 participantsStarted May 2007

Little Rock, Arkansas, United States • Duarte, California, United States • Los Angeles, California, United States +17 more locations

COMPLETEDNA< 1 mile

Clinical Evaluation of the Blazer Open-Irrigated Ablation Catheter for the Treatment of Paroxysmal Atrial Fibrillation

NCT01687166

The purpose of this study is to establish the safety and effectiveness of the Blazer Open-Irrigated radiofrequency ablation catheter for the treatment of drug refractory, recurrent, symptomatic, paroxysmal atrial fibrillation.

Paroxysmal Atrial Fibrillation (PAF)

Boston Scientific Corporation398 participantsStarted Oct 2012

Birmingham, Alabama, United States • Huntsville, Alabama, United States • Redwood City, California, United States +35 more locations

Trial of Dasatinib in Advanced Sarcomas

Clinical Evaluation of the Blazer Open-Irrigated Ablation Catheter for the Treatment of Paroxysmal Atrial Fibrillation

Find Trials by Condition in Houston

Letrozole Versus Observation in Patients With Newly Diagnosed Uterine Leiomyosarcoma

Safety Study of Oral Azacitidine (CC-486) as Maintenance Therapy After Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) in Participants With Acute Myeloid Leukemia (AML) or Myelodysplastic Syndromes (MDS).

Safety and Efficacy of Idelalisib in Relapsed or Refractory Hodgkin Lymphoma

Pharmacokinetics and Safety of MM36 Topical Ointment in Pediatric Subjects With Atopic Dermatitis

R-21 Colorectal Cancer Screening (CRCS) Pilot Trial

Study to Evaluate the Safety and Efficacy of E/C/F/TAF (Genvoya®) Versus E/C/F/TDF (Stribild®) in HIV-1 Positive, Antiretroviral Treatment-Naive Adults

A Study of Idelalisib and Rituximab in Elderly Patients With Untreated CLL or SLL

Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed-Dose Combination ± Ribavirin for the Treatment of HCV (ION-3)

Efficacy and Safety of Ledipasvir/Sofosbuvir Fixed-Dose Combination for 12 Weeks in Subjects With Chronic Genotype 1 or 4 HCV and HIV-1 Co-infection

A Study Of Deoxycoformycin(DCF)/Pentostatin In Lymphoid Malignancies

Efficacy and Safety of Idelalisib in Combination With Bendamustine and Rituximab in Adults With Previously Untreated Chronic Lymphocytic Leukemia

Efficacy and Safety of Idelalisib (GS-1101) in Combination With Bendamustine and Rituximab for Previously Treated Indolent Non-Hodgkin Lymphomas

Efficacy And Safety Of Sofosbuvir/Velpatasvir Fixed Dose Combination With Ribavirin in Chronic HCV Infected Adults Who Participated in a Prior Gilead Sponsored HCV Treatment Study

A Study of Baricitinib (LY3009104) in Participants With Systemic Lupus Erythematosus (SLE)

Safety Study of HemaMax™ (rHuIL-12) to Treat Acute Radiation Syndrome

ALK21-025: Vivitrol's Cost and Treatment Outcomes Registry

Efficacy and Safety of Idelalisib in Combination With Obinutuzumab Compared to Chlorambucil in Combination With Obinutuzumab for Previously Untreated Chronic Lymphocytic Leukemia

Ledipasvir/Sofosbuvir Fixed-Dose Combination Plus Ribavirin in Participants With Chronic HCV With Advanced Liver Disease or Post-Liver Transplant